Clinical Trial Update: A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight [Phase 1]

View source ↗

Summary

Suzhou Alphamab is conducting a Phase 1 clinical trial of KN069 in adults with overweight or obesity, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• KN069

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Overweight or Obesity | Phase 1 | Status: RECRUITING